AngioDynamics Inc
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall … Read more
Market Cap & Net Worth: AngioDynamics Inc (ANGO)
AngioDynamics Inc (NASDAQ:ANGO) has a market capitalization of $439.79 Million ($439.79 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #12016 globally and #5250 in its home market, demonstrating a -1.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AngioDynamics Inc's stock price $10.67 by its total outstanding shares 41217386 (41.22 Million).
AngioDynamics Inc Market Cap History: 2015 to 2026
AngioDynamics Inc's market capitalization history from 2015 to 2026. Data shows change from $500.38 Million to $439.79 Million (-1.48% CAGR).
Index Memberships
AngioDynamics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.02% | #327 of 976 |
|
NASDAQ Composite
IXIC
|
$33.26 Trillion | 0.00% | #1197 of 3165 |
Weight: AngioDynamics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
AngioDynamics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AngioDynamics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.81x
AngioDynamics Inc's market cap is 1.81 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $695.34 Million | $353.69 Million | -$43.59 Million | 1.97x | N/A |
| 2017 | $685.45 Million | $349.64 Million | -$7.05 Million | 1.96x | N/A |
| 2018 | $829.71 Million | $344.29 Million | $16.34 Million | 2.41x | 50.79x |
| 2019 | $659.89 Million | $359.48 Million | $61.34 Million | 1.84x | 10.76x |
| 2020 | $631.86 Million | $264.16 Million | -$166.79 Million | 2.39x | N/A |
| 2021 | $1.14 Billion | $291.01 Million | -$31.55 Million | 3.91x | N/A |
| 2022 | $567.56 Million | $316.22 Million | -$26.55 Million | 1.79x | N/A |
| 2023 | $323.14 Million | $338.75 Million | -$52.44 Million | 0.95x | N/A |
| 2024 | $377.55 Million | $303.91 Million | -$184.35 Million | 1.24x | N/A |
| 2025 | $529.23 Million | $292.50 Million | -$33.99 Million | 1.81x | N/A |
Competitor Companies of ANGO by Market Capitalization
Companies near AngioDynamics Inc in the global market cap rankings as of March 18, 2026.
Key companies related to AngioDynamics Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #99 globally with a market cap of $170.64 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #355 globally with a market cap of $61.46 Billion USD ( €59.87 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.52 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #99 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.64 Billion | $483.46 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #355 | EssilorLuxottica S. A. | PA:EL | $61.46 Billion | €203.90 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.52 Billion | $160.27 |
AngioDynamics Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, AngioDynamics Inc's market cap moved from $500.38 Million to $ 439.79 Million, with a yearly change of -1.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $439.79 Million | -16.90% |
| 2025 | $529.23 Million | +40.17% |
| 2024 | $377.55 Million | +16.84% |
| 2023 | $323.14 Million | -43.06% |
| 2022 | $567.56 Million | -50.07% |
| 2021 | $1.14 Billion | +79.91% |
| 2020 | $631.86 Million | -4.25% |
| 2019 | $659.89 Million | -20.47% |
| 2018 | $829.71 Million | +21.05% |
| 2017 | $685.45 Million | -1.42% |
| 2016 | $695.34 Million | +38.96% |
| 2015 | $500.38 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of AngioDynamics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $439.79 Million USD |
| MoneyControl | $439.79 Million USD |
| MarketWatch | $439.79 Million USD |
| marketcap.company | $439.79 Million USD |
| Reuters | $439.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.